Back to Browse Journals » Advances and Applications in Bioinformatics and Chemistry » Volume 1

A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells

Authors Junko H Ohyashiki, Ryoko Hamamura, Chiaki Kobayashi, Yu Zhang, Kazuma Ohyashiki

Published 30 October 2008 Volume 2008:1 Pages 85—98

DOI https://doi.org/10.2147/AABC.S4133

Review by Single-blind

Peer reviewer comments 4

Junko H Ohyashiki1, Ryoko Hamamura2, Chiaki Kobayashi2, Yu Zhang2, Kazuma Ohyashiki2

1Intractable Immune System Disease Research Center, Tokyo Medical University, Tokyo, Japan; 2First Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan

Abstract: There is a need to identify the regulatory gene interaction of anticancer drugs on target cancer cells. Whole genome expression profiling offers promise in this regard, but can be complicated by the challenge of identifying the genes affected by hundreds to thousands of genes that induce changes in expression. A proteasome inhibitor, bortezomib, could be a potential therapeutic agent in treating adult T-cell leukemia (ATL) patients, however, the underlying mechanism by which bortezomib induces cell death in ATL cells via gene regulatory network has not been fully elucidated. Here we show that a Bayesian statistical framework by VoyaGene® identified a secreted protein acidic and rich in cysteine (SPARC) gene, a tumor-invasiveness related gene, as a possible modulator of bortezomib-induced cell death in ATL cells. Functional analysis using RNAi experiments revealed that inhibition of the expression SPARC by siRNA enhanced the apoptotic effect of bortezomib on ATL cells in accordance with an increase of cleaved caspase 3. Targeting SPARC may help to treat ATL patients in combination with bortezomib. This work shows that a network biology approach can be used advantageously to identify the genetic interaction related to anticancer effects.

Keywords: network biology, adult T cell leukemia, bortezomib, SPARC

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely

Ohyashiki JH, Ohtsuki K, Mizoguchi I, Yoshimoto T, Katagiri S, Umezu T, Ohyashiki K

Drug Design, Development and Therapy 2014, 8:1151-1159

Published Date: 25 August 2014

Readers of this article also read:

Polymersomes containing quantum dots for cellular imaging

Camblin M, Detampel P, Kettiger H, Wu D, Balasubramanian V, Huwyler J

International Journal of Nanomedicine 2014, 9:2287-2298

Published Date: 12 May 2014

Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier

Chaturvedi M, Molino Y, Sreedhar B, Khrestchatisky M, Kaczmarek L

International Journal of Nanomedicine 2014, 9:575-588

Published Date: 20 January 2014

Statistical analysis of repeated microRNA high-throughput data with application to human heart failure: a review of methodology

Rai SN, Ray HE, Yuan X, Pan J, Hamid T, Prabhu SD

Open Access Medical Statistics 2012, 2:21-31

Published Date: 13 April 2012

Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation

Ehrlich JR, Hammwöhner M, Goette A

Research Reports in Clinical Cardiology 2012, 3:11-21

Published Date: 18 January 2012

Bilateral cuffed tunnelled femoral dialysis catheters

Hinchliffe WT, Ahmed S, Mansy H

International Journal of Nephrology and Renovascular Disease 2011, 4:137-138

Published Date: 1 November 2011

Increment of diversity with quadratic discriminant analysis – an efficient tool for sequence pattern recognition in bioinformatics

Jun Lu, Liaofu Luo, Lirong Zhang, et al

Open Access Bioinformatics 2010, 2:89-96

Published Date: 4 August 2010